UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 49

Sortiert nach

Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy

Journal of clinical oncology, 2011-03, Vol.29 (7), p.859-867

2011

Link zum Volltext

Verfügbarkeit prüfen

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer

Clinical cancer research, 2008-12, Vol.14 (23), p.7861-7870

2008

Link zum Volltext

Verfügbarkeit prüfen

HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib

Molecular cancer therapeutics, 2017-01, Vol.16 (1), p.228-238

2017

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials

Clinical cancer research, 2005-09, Vol.11 (18), p.6598-6607

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)

Breast cancer research and treatment, 2013-02, Vol.138 (1), p.99-108

2013

Link zum Volltext

Verfügbarkeit prüfen

Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic

Antibiotics (Basel), 2021-02, Vol.10 (2), p.182

2021

Link zum Volltext

Verfügbarkeit prüfen

HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics

Breast cancer research and treatment, 2014-05, Vol.145 (1), p.193-203

2014

Link zum Volltext

Verfügbarkeit prüfen

Chromosome 17 Polysomy without Human Epidermal Growth Factor Receptor 2 Amplification Does Not Predict Response to Lapatinib Plus Paclitaxel Compared with Paclitaxel in Metastatic Breast Cancer

Clinical cancer research, 2010-02, Vol.16 (4), p.1281-1288

2010

Link zum Volltext

Verfügbarkeit prüfen

Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice

Archives of pathology & laboratory medicine (1976), 2016-11, Vol.140 (11), p.1250-1258

2016

Link zum Volltext

Verfügbarkeit prüfen

PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

Clinical cancer research, 2015-05, Vol.21 (9), p.2065-2074

2015

Link zum Volltext

Verfügbarkeit prüfen

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

JAMA oncology, 2019-03, Vol.5 (3), p.366

2019

Link zum Volltext

Verfügbarkeit prüfen

Concordance study of HER2 fluorescence in situ hybridization (FISH) assays in upper gastrointestinal (UGI) adenocarcinomas

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.4072-4072

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3557: Reduced ovarian hormones & reduced mammographic & MRI determined breast density in BRCA carriers following a hormonal chemo-prevention regimen of gonadotropin releasing hormone agonist (GnRHA) & low-dose add-back estrogen & testosterone

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3557-3557

2012

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic evaluation of HER-2 as a moleculartarget : An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials

Clinical cancer research, 2005, Vol.11 (18), p.6598-6607

2005

Link zum Volltext

Verfügbarkeit prüfen

Leukocyturia in Women with Diabetes and Its Clinical Implications

Archives of medical research, 2000-03, Vol.31 (2), p.210-215

2000

Link zum Volltext

Verfügbarkeit prüfen

Urgencia obstétrica y saber popular en Tenejapa, Chiapas

Perinatología y reproducción humana, 2006-12, Vol.20 (4), p.60-68

2006

Link zum Volltext

Verfügbarkeit prüfen

High prevalence of chlamydia pneumoniae seropositivity in mexican patients with ischemic heart disease

Archives of medical research, 2004-07, Vol.35 (4), p.318-323

2004

Link zum Volltext

Verfügbarkeit prüfen

Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages

OncoTargets and therapy, 2022-01, Vol.15, p.1211-1220

2022

Link zum Volltext

Verfügbarkeit prüfen

Response to Article "Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages" [Response to Letter]

OncoTargets and therapy, 2022-01, Vol.15, p.1543-1544

2022

Link zum Volltext

Verfügbarkeit prüfen

Differential Expression of Proteins in an Atypical Presentation of Autoimmune Lymphoproliferative Syndrome

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5366

2022

Link zum Volltext

Verfügbarkeit prüfen

Morphology of the feeding apparatus of cave shrimps of the genus Typhlatya (Decapoda: Atyidae) from the Yucatán Peninsula and comparison with epigean species

Revista mexicana de biodiversidad, 2023-05, Vol.94, p.e945230

2023

Link zum Volltext

Verfügbarkeit prüfen

A novel, sequencing-free strategy for the functional characterization of Taenia solium proteomic fingerprint

PLoS neglected tropical diseases, 2021-02, Vol.15 (2), p.e0009104-e0009104

2021

Link zum Volltext

Verfügbarkeit prüfen

Quality of Life in Mexican Older Adults: Factor Structure of the SF-36 Questionnaire

Healthcare (Basel), 2022-01, Vol.10 (2), p.200

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(43)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(49)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Alteration of Topoisomerase II–Alpha Gene in Human Breast Cancer: Association With Responsiveness to Anthracycline-Based Chemotherapy

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast Cancer

HER2 Status in Advanced or Metastatic Gastric, Esophageal, or Gastroesophageal Adenocarcinoma for Entry to the TRIO-013/LOGiC Trial of Lapatinib

Diagnostic Evaluation of HER-2 as a Molecular Target: An Assessment of Accuracy and Reproducibility of Laboratory Testing in Large, Prospective, Randomized Clinical Trials

Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005)

Antimicrobial Resistance Patterns and Antibiotic Use during Hospital Conversion in the COVID-19 Pandemic

HER2 and TOP2A amplification in a hospital-based cohort of breast cancer patients: associations with patient and tumor characteristics

Chromosome 17 Polysomy without Human Epidermal Growth Factor Receptor 2 Amplification Does Not Predict Response to Lapatinib Plus Paclitaxel Compared with Paclitaxel in Metastatic Breast Cancer

HER2 Gene Amplification Testing by Fluorescent In Situ Hybridization (FISH): Comparison of the ASCO-College of American Pathologists Guidelines With FISH Scores Used for Enrollment in Breast Cancer International Research Group Clinical Trials

Assessing the New American Society of Clinical Oncology/College of American Pathologists Guidelines for HER2 Testing by Fluorescence In Situ Hybridization: Experience of an Academic Consultation Practice

PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance

Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines

Concordance study of HER2 fluorescence in situ hybridization (FISH) assays in upper gastrointestinal (UGI) adenocarcinomas

HER2 gene amplification testing by fluorescence in situ hybridization (FISH): Comparison of the ASCO-CAP guidelines with FISH scores used for enrollment in breast cancer international research group (BCIRG) clinical trials

Abstract 3557: Reduced ovarian hormones & reduced mammographic & MRI determined breast density in BRCA carriers following a hormonal chemo-prevention regimen of gonadotropin releasing hormone agonist (GnRHA) & low-dose add-back estrogen & testosterone

Diagnostic evaluation of HER-2 as a moleculartarget : An assessment of accuracy and reproducibility of laboratory testing in large, prospective, randomized clinical trials

Leukocyturia in Women with Diabetes and Its Clinical Implications

Urgencia obstétrica y saber popular en Tenejapa, Chiapas

High prevalence of chlamydia pneumoniae seropositivity in mexican patients with ischemic heart disease

Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages

Response to Article "Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages" [Response to Letter]

Differential Expression of Proteins in an Atypical Presentation of Autoimmune Lymphoproliferative Syndrome

Morphology of the feeding apparatus of cave shrimps of the genus Typhlatya (Decapoda: Atyidae) from the Yucatán Peninsula and comparison with epigean species

A novel, sequencing-free strategy for the functional characterization of Taenia solium proteomic fingerprint

Quality of Life in Mexican Older Adults: Factor Structure of the SF-36 Questionnaire

Suchergebnisse filtern